Papers - KAJIYAMA, Hiroaki
-
Clinical significance and predicting indicators of post-cancer-treatment survival in terminally ill patients with ovarian cancer
Utsumi Fumi, Kajiyama Hiroaki, Niimi Kaoru, Sekiya Ryuichiro, Sakata Jun, Suzuki Shiro, Shibata Kiyosumi, Mizuno Mika, Kikkawa Fumitaka
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH Vol. 43 ( 2 ) page： 365 - 370 2017.2
-
Future perspective of strategic non-thermal plasma therapy for cancer treatment
Kajiyama Hiroaki, Utsumi Fumi, Nakamura Kae, Tanaka Hiromasa, Toyokuni Shinya, Hori Masaru, Kikkawa Fumitaka
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION Vol. 60 ( 1 ) page： 33 - 38 2017.1
-
c-Rel Promotes Invasion of Choriocarcinoma Cells via PI3K/AKT Signaling
Sekiya Yoko, Yamamoto Eiko, Niimi Kaoru, Nishino Kimihiro, Nakamura Kenichi, Kotani Tomomi, Kajiyama Hiroaki, Shibata Kiyosumi, Kikkawa Fumitaka
ONCOLOGY Vol. 92 ( 5 ) page： 299 - 310 2017
-
A recurrence-predicting prognostic factor for patients with ovarian clear-cell adenocarcinoma at reproductive age. Reviewed
Kajiyama H, Mizuno M, Shibata K, Umezu T, Suzuki S, Yamamoto E, Mitsui H, Sekiya R, Niimi K, Kawai M, Nagasaka T, Kikkawa F.
Int J Clin Oncol. Vol. 19 ( 5 ) page： 921-7 2014.10
-
Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities? Reviewed
Kajiyama H, Mizuno M, Shibata K, Umezu T, Suzuki S, Yamamoto E, Mitsui H, Sekiya R, Niimi K, Kawai M, Nagasaka T, Kikkawa F.
Eur J Obstet Gynecol Reprod Biol. Vol. 181 page： 305-10 2014.10
-
PLAGL2 regulates actin cytoskeletal architecture and cell migration. Reviewed
Sekiya R, Maeda M, Yuan H, Asano E, Hyodo T, Hasegawa H, Ito S, Shibata K, Hamaguchi M, Kikkawa F, Kajiyama H, Senga T.
Carcinogenesis. 2014.9
-
Expression of the miR200 family of microRNAs in mesothelial cells suppresses the dissemination of ovarian cancer cells. Reviewed
Expression of the miR200 family of microRNAs in mesothelial cells suppresses the dissemination of ovarian cancer cells.
Mol Cancer Ther. Vol. 13 ( 8 ) page： 2081-91 2014.8
-
Selective cytotoxicity of indirect nonequilibrium atmospheric pressure plasma against ovarian clear-cell carcinoma. Reviewed
Utsumi F, Kajiyama H, Nakamura K, Tanaka H, Hori M, Kikkawa F.
Springerplus. page： 10.1186/2193-1801-3-398 2014.7
-
Survival benefit of taxane plus platinum in recurrent ovarian cancer with non-clear cell, non-mucinous histology. Reviewed
Kajiyama H, Shibata K, Mizuno M, Umezu T, Suzuki S, Sekiya R, Niimi K, Mitsui H, Yamamoto E, Kawai M, Nagasaka T, Kikkawa F.
J Gynecol Oncol. Vol. 25 ( 1 ) page： 43-50 2014.4
-
Recurrence-predicting prognostic factors for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery: a multi-institutional study. Reviewed
Kajiyama H, Mizuno M, Shibata K, Yamamoto E, Kawai M, Nagasaka T, Kikkawa F.
Eur J Obstet Gynecol Reprod Biol. page： 10.1016/j.ejogrb.2014.01.014. 2014.4
-
Is there any association between where patients spend the end of life and survival after anticancer treatment for gynecologic malignancy? Reviewed
Kajiyama H, Utsumi F, Higashi M, Sakata J, Sekiya R, Mizuno M, Umezu T, Suzuki S, Yamamoto E, Mitsui H, Niimi K, Shibata K, Kikkawa F.
J Palliat Med. Vol. 17 ( 3 ) page： 325-30 2014.3
-
Effect of indirect nonequilibrium atmospheric pressure plasma on anti-proliferative activity against chronic chemo-resistant ovarian cancer cells in vitro and in vivo. Reviewed
Utsumi F, Kajiyama H, Nakamura K, Tanaka H, Mizuno M, Ishikawa K, Kondo H, Kano H, Hori M, Kikkawa F.
PLoS One. page： 10.1371/journal.pone.0081576. 2013.12
-
Long-term clinical outcome of patients with recurrent epithelial ovarian carcinoma: is it the same for each histological type? Reviewed
Vol. 22 ( 3 ) page： 394-9 2012.3
-
Postrecurrent oncologic outcome of patients with ovarian clear cell carcinoma. Reviewed
Kajiyama H, Shibata K, Mizuno M, Yamamoto E, Fujiwara S, Umezu T, Suzuki S, Nakanishi T, Nagasaka T, Kikkawa F.
Int J Gynecol Cancer. page： 10.1097/IGC.0b013e3182540145. 2012
-
Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement. Reviewed
page： doi:pii: S0046-8177(12)00190-6 2012
-
Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery. Reviewed
Kajiyama H, Shibata K, Mizuno M, Umezu T, Suzuki S, Nawa A, Kawai M, Nagasaka T, Kikkawa F.
Br J Cancer Vol. 105 ( 9 ) page： 1288-94 2011.11
-
Fertility-sparing surgery in young women with invasive epithelial ovarian cancer. Reviewed
Kajiyama H, Shibata K, Suzuki S, Ino K, Nawa A, Kawai M, Nagasaka T, KikkawaF.
Eur J Surg Oncol. Vol. 36 ( 4 ) page： 404-8 2010
-
The expression ofdipeptidyl peptidase IV (DPPIV/CD26) is associated with enhanced chemosensitivity to paclitaxel in epithelial ovarian carcinoma cells. Reviewed
Kajiyama H, Shibata K, Ino K, Mizutani S, Nawa A, Kikkawa F
Cancer Sci. Vol. 101 ( 2 ) page： 347-54 2010
-
*Fertility-sparing surgery in young women with invasive epithelial ovarian cancer. Reviewed
Kajiyama H, Shibata K, Suzuki S, Ino K, Nawa A, Kawai M, Nagasaka T, Kikkawa F.
Eur J Surg Oncol. 2010 Vol. in press 2010
-
The expression of dipeptidyl peptidase IV (DPPIV/CD26) is associated with enhanced chemosensitivity to paclitaxel in epithelial ovarian carcinoma cells. Reviewed
Kajiyama H, Shibata K, Ino K, Mizutani S, Nawa A, Kikkawa F.
Cancer Sci. 2009 Vol. in press 2009